共 36 条
[1]
AstraZeneca, BIOETH ASTRAZENECA G
[2]
Open-label, multicenter, Phase Ib study to assess safety, tolerability and efficacy of adavosertib monotherapy in patients with advanced solid tumors: Expansion cohorts
[J].
Bauer, Todd M.
;
Moore, Kathleen
;
Rader, Janet S.
;
Simpkins, Fiona
;
Mita, Alain
;
Beck, J. Thaddeus
;
Hart, Lowell
;
Chu, Quincy
;
Oza, Amit
;
Tinker, Anna V.
;
So, Karen
;
Imedio, Esteban Rodrigo
;
Kumar, Sanjeev
;
Mugundu, Ganesh M.
;
Jenkins, Suzanne
;
Chmielecki, Juliann
;
Jones, Suzanne
;
Spigel, David R.
;
Fu, Siqing
.
CANCER RESEARCH,
2019, 79 (13)

Bauer, Todd M.
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA
Tennessee Oncol, Nashville, TN USA Sarah Cannon Res Inst, Nashville, TN USA

Moore, Kathleen
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Oklahoma, Oklahoma City, OK USA Sarah Cannon Res Inst, Nashville, TN USA

Rader, Janet S.
论文数: 0 引用数: 0
h-index: 0
机构:
Med Coll Wisconsin, Milwaukee, WI 53226 USA Sarah Cannon Res Inst, Nashville, TN USA

Simpkins, Fiona
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Sarah Cannon Res Inst, Nashville, TN USA

Mita, Alain
论文数: 0 引用数: 0
h-index: 0
机构:
Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA Sarah Cannon Res Inst, Nashville, TN USA

Beck, J. Thaddeus
论文数: 0 引用数: 0
h-index: 0
机构:
Highlands Oncol Grp, Fayetteville, AZ USA Sarah Cannon Res Inst, Nashville, TN USA

Hart, Lowell
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Ft Myers, FL USA Sarah Cannon Res Inst, Nashville, TN USA

Chu, Quincy
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada Sarah Cannon Res Inst, Nashville, TN USA

Oza, Amit
论文数: 0 引用数: 0
h-index: 0
机构:
Princess Margaret Canc Ctr, Toronto, ON, Canada Sarah Cannon Res Inst, Nashville, TN USA

Tinker, Anna V.
论文数: 0 引用数: 0
h-index: 0
机构:
BC Canc, Vancouver, BC, Canada Sarah Cannon Res Inst, Nashville, TN USA

So, Karen
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Cambridge, England Sarah Cannon Res Inst, Nashville, TN USA

Imedio, Esteban Rodrigo
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Cambridge, England Sarah Cannon Res Inst, Nashville, TN USA

Kumar, Sanjeev
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Cambridge, England Sarah Cannon Res Inst, Nashville, TN USA

Mugundu, Ganesh M.
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Boston, MA USA Sarah Cannon Res Inst, Nashville, TN USA

Jenkins, Suzanne
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Translat Sci, IMED Biotech Unit, Oncol, Waltham, MA USA Sarah Cannon Res Inst, Nashville, TN USA

Chmielecki, Juliann
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Translat Sci, IMED Biotech Unit, Oncol, Waltham, MA USA Sarah Cannon Res Inst, Nashville, TN USA

Jones, Suzanne
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA Sarah Cannon Res Inst, Nashville, TN USA

Spigel, David R.
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA
Tennessee Oncol, Nashville, TN USA Sarah Cannon Res Inst, Nashville, TN USA

Fu, Siqing
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Sarah Cannon Res Inst, Nashville, TN USA
[3]
A phase Ib, open-label, multicenter study to assess the safety, tolerability, pharmacokinetics, and antitumor activity of AZD1775 monotherapy in patients with advanced solid tumors: initial findings
[J].
Bauer, Todd M.
;
Jones, Suzanne F.
;
Greenlees, Carol
;
Cook, Carl
;
Mugundu, Ganesh M.
;
Jewsbury, Philip J.
;
Pierce, Andrew J.
;
O'Connor, Mark J.
;
Johnson, Melissa L.
;
Beck, J. Thaddeus
;
Moore, Kathleen N.
;
Hart, Lowell L.
;
Infante, Jeffery R.
;
Burris, Howard A.
;
Spigel, David
.
CANCER RESEARCH,
2016, 76

Bauer, Todd M.
论文数: 0 引用数: 0
h-index: 0

Jones, Suzanne F.
论文数: 0 引用数: 0
h-index: 0

Greenlees, Carol
论文数: 0 引用数: 0
h-index: 0

Cook, Carl
论文数: 0 引用数: 0
h-index: 0

Mugundu, Ganesh M.
论文数: 0 引用数: 0
h-index: 0

Jewsbury, Philip J.
论文数: 0 引用数: 0
h-index: 0

Pierce, Andrew J.
论文数: 0 引用数: 0
h-index: 0

O'Connor, Mark J.
论文数: 0 引用数: 0
h-index: 0

Johnson, Melissa L.
论文数: 0 引用数: 0
h-index: 0

Beck, J. Thaddeus
论文数: 0 引用数: 0
h-index: 0

Moore, Kathleen N.
论文数: 0 引用数: 0
h-index: 0

Hart, Lowell L.
论文数: 0 引用数: 0
h-index: 0

Infante, Jeffery R.
论文数: 0 引用数: 0
h-index: 0

Burris, Howard A.
论文数: 0 引用数: 0
h-index: 0

Spigel, David
论文数: 0 引用数: 0
h-index: 0
[4]
Cell death by mitotic catastrophe: a molecular definition
[J].
Castedo, M
;
Perfettini, JL
;
Roumie, T
;
Andreau, K
;
Medema, R
;
Kroemer, G
.
ONCOGENE,
2004, 23 (16)
:2825-2837

Castedo, M
论文数: 0 引用数: 0
h-index: 0
机构: Inst Gustave Roussy, CNRS, UMR 8125, F-94805 Villejuif, France

Perfettini, JL
论文数: 0 引用数: 0
h-index: 0
机构: Inst Gustave Roussy, CNRS, UMR 8125, F-94805 Villejuif, France

Roumie, T
论文数: 0 引用数: 0
h-index: 0
机构: Inst Gustave Roussy, CNRS, UMR 8125, F-94805 Villejuif, France

Andreau, K
论文数: 0 引用数: 0
h-index: 0
机构: Inst Gustave Roussy, CNRS, UMR 8125, F-94805 Villejuif, France

论文数: 引用数:
h-index:
机构:

Kroemer, G
论文数: 0 引用数: 0
h-index: 0
机构: Inst Gustave Roussy, CNRS, UMR 8125, F-94805 Villejuif, France
[5]
Dose Escalation Trial of the Wee1 Inhibitor Adavosertib (AZD1775) in Combination With Gemcitabine and Radiation for Patients With Locally Advanced Pancreatic Cancer
[J].
Cuneo, Kyle C.
;
Morgan, Meredith A.
;
Sahai, Vaibhav
;
Schipper, Matthew J.
;
Parsels, Leslie A.
;
Parsels, Joshua D.
;
Devasia, Theresa
;
Al-Hawaray, Mahmoud
;
Cho, Clifford S.
;
Nathan, Hari
;
Maybaum, Jonathan
;
Zalupski, Mark M.
;
Lawrence, Theodore S.
.
JOURNAL OF CLINICAL ONCOLOGY,
2019, 37 (29)
:2643-+

Cuneo, Kyle C.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Morgan, Meredith A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Sahai, Vaibhav
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

论文数: 引用数:
h-index:
机构:

Parsels, Leslie A.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Parsels, Joshua D.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Devasia, Theresa
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Al-Hawaray, Mahmoud
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Cho, Clifford S.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Nathan, Hari
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Maybaum, Jonathan
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Zalupski, Mark M.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA

Lawrence, Theodore S.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Michigan, Ann Arbor, MI 48109 USA Univ Michigan, Ann Arbor, MI 48109 USA
[6]
Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
[J].
Do, Khanh
;
Wilsker, Deborah
;
Ji, Jiuping
;
Zlott, Jennifer
;
Freshwater, Tomoko
;
Kinders, Robert J.
;
Collins, Jerry
;
Chen, Alice P.
;
Doroshow, James H.
;
Kummar, Shivaani
.
JOURNAL OF CLINICAL ONCOLOGY,
2015, 33 (30)
:3409-+

Do, Khanh
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USA

Wilsker, Deborah
论文数: 0 引用数: 0
h-index: 0
机构:
Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA NCI, Bethesda, MD 20892 USA

Ji, Jiuping
论文数: 0 引用数: 0
h-index: 0
机构:
Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA NCI, Bethesda, MD 20892 USA

Zlott, Jennifer
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USA

Freshwater, Tomoko
论文数: 0 引用数: 0
h-index: 0
机构:
Merck Res Labs Oncol, Boston, MA USA NCI, Bethesda, MD 20892 USA

Kinders, Robert J.
论文数: 0 引用数: 0
h-index: 0
机构:
Frederick Natl Lab Canc Res, Leidos Biomed Res, Frederick, MD USA NCI, Bethesda, MD 20892 USA

Collins, Jerry
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USA

Chen, Alice P.
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USA

Doroshow, James H.
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USA

Kummar, Shivaani
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Bethesda, MD 20892 USA NCI, Bethesda, MD 20892 USA
[7]
Wee1 kinase as a target for cancer therapy
[J].
Do, Khanh
;
Doroshow, James H.
;
Kummar, Shivaani
.
CELL CYCLE,
2013, 12 (19)
:3159-3164

Do, Khanh
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Ctr Canc Res, Bethesda, MD 20892 USA NCI, Ctr Canc Res, Bethesda, MD 20892 USA

Doroshow, James H.
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Ctr Canc Res, Bethesda, MD 20892 USA
NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA NCI, Ctr Canc Res, Bethesda, MD 20892 USA

Kummar, Shivaani
论文数: 0 引用数: 0
h-index: 0
机构:
NCI, Ctr Canc Res, Bethesda, MD 20892 USA
NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA NCI, Ctr Canc Res, Bethesda, MD 20892 USA
[8]
A Phase Ib study of Wee1 inhibitor adavosertib in patients with advanced solid tumors
[J].
Falchook, Gerald S.
;
Sachdev, Jasgit
;
Imedio, Esteban Rodrigo
;
Kumar, Sanjeev
;
Mugundu, Ganesh
;
Chmielecki, Juliann
;
Jones, Suzanne
;
Spigel, David R.
;
Johnson, Melissa
.
CANCER RESEARCH,
2019, 79 (13)

Falchook, Gerald S.
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst HealthONE, Denver, CO USA Sarah Cannon Res Inst HealthONE, Denver, CO USA

Sachdev, Jasgit
论文数: 0 引用数: 0
h-index: 0
机构:
HonorHlth Res Inst, Scottsdale, AZ USA Sarah Cannon Res Inst HealthONE, Denver, CO USA

Imedio, Esteban Rodrigo
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Cambridge, England Sarah Cannon Res Inst HealthONE, Denver, CO USA

Kumar, Sanjeev
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Cambridge, England Sarah Cannon Res Inst HealthONE, Denver, CO USA

Mugundu, Ganesh
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Quantitat Clin Pharmacol, IMED Biotech Unit, Boston, MA USA Sarah Cannon Res Inst HealthONE, Denver, CO USA

Chmielecki, Juliann
论文数: 0 引用数: 0
h-index: 0
机构:
AstraZeneca, Translat Sci, IMED Biotech Unit, Oncol, Waltham, MA USA Sarah Cannon Res Inst HealthONE, Denver, CO USA

Jones, Suzanne
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA Sarah Cannon Res Inst HealthONE, Denver, CO USA

Spigel, David R.
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA
Tennessee Oncol, Nashville, TN USA Sarah Cannon Res Inst HealthONE, Denver, CO USA

Johnson, Melissa
论文数: 0 引用数: 0
h-index: 0
机构:
Sarah Cannon Res Inst, Nashville, TN USA
Tennessee Oncol, Nashville, TN USA Sarah Cannon Res Inst HealthONE, Denver, CO USA
[9]
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
[J].
Frampton, Garrett M.
;
Fichtenholtz, Alex
;
Otto, Geoff A.
;
Wang, Kai
;
Downing, Sean R.
;
He, Jie
;
Schnall-Levin, Michael
;
White, Jared
;
Sanford, Eric M.
;
An, Peter
;
Sun, James
;
Juhn, Frank
;
Brennan, Kristina
;
Iwanik, Kiel
;
Maillet, Ashley
;
Buell, Jamie
;
White, Emily
;
Zhao, Mandy
;
Balasubramanian, Sohail
;
Terzic, Selmira
;
Richards, Tina
;
Banning, Vera
;
Garcia, Lazaro
;
Mahoney, Kristen
;
Zwirko, Zac
;
Donahue, Amy
;
Beltran, Himisha
;
Mosquera, Juan Miguel
;
Rubin, Mark A.
;
Dogan, Snjezana
;
Hedvat, Cyrus V.
;
Berger, Michael F.
;
Pusztai, Lajos
;
Lechner, Matthias
;
Boshoff, Chris
;
Jarosz, Mirna
;
Vietz, Christine
;
Parker, Alex
;
Miller, Vincent A.
;
Ross, Jeffrey S.
;
Curran, John
;
Cronin, Maureen T.
;
Stephens, Philip J.
;
Lipson, Doron
;
Yelensky, Roman
.
NATURE BIOTECHNOLOGY,
2013, 31 (11)
:1023-+

Frampton, Garrett M.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Fichtenholtz, Alex
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Otto, Geoff A.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Wang, Kai
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Downing, Sean R.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

He, Jie
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Schnall-Levin, Michael
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

White, Jared
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Sanford, Eric M.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

An, Peter
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Sun, James
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Juhn, Frank
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Brennan, Kristina
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Iwanik, Kiel
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Maillet, Ashley
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Buell, Jamie
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

White, Emily
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Zhao, Mandy
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Balasubramanian, Sohail
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Terzic, Selmira
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Richards, Tina
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Banning, Vera
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Garcia, Lazaro
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Mahoney, Kristen
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Zwirko, Zac
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Donahue, Amy
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Beltran, Himisha
论文数: 0 引用数: 0
h-index: 0
机构:
Cornell Univ, Weill Med Coll, Dept Med, Div Hematol & Med Oncol, New York, NY 10021 USA
Weill Cornell Med Coll, Inst Precis Med, New York, NY USA
New York Presbyterian Hosp, New York, NY USA Fdn Med, Cambridge, MA USA

Mosquera, Juan Miguel
论文数: 0 引用数: 0
h-index: 0
机构:
Weill Cornell Med Coll, Inst Precis Med, New York, NY USA
New York Presbyterian Hosp, New York, NY USA
Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA Fdn Med, Cambridge, MA USA

Rubin, Mark A.
论文数: 0 引用数: 0
h-index: 0
机构:
Weill Cornell Med Coll, Inst Precis Med, New York, NY USA
New York Presbyterian Hosp, New York, NY USA
Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA Fdn Med, Cambridge, MA USA

Dogan, Snjezana
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA Fdn Med, Cambridge, MA USA

Hedvat, Cyrus V.
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA Fdn Med, Cambridge, MA USA

Berger, Michael F.
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA Fdn Med, Cambridge, MA USA

论文数: 引用数:
h-index:
机构:

Lechner, Matthias
论文数: 0 引用数: 0
h-index: 0
机构:
UCL, UCL Canc Inst, London, England Fdn Med, Cambridge, MA USA

Boshoff, Chris
论文数: 0 引用数: 0
h-index: 0
机构:
UCL, UCL Canc Inst, London, England Fdn Med, Cambridge, MA USA

Jarosz, Mirna
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Vietz, Christine
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Parker, Alex
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Miller, Vincent A.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Ross, Jeffrey S.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA
Albany Med Coll, Dept Pathol & Lab Med, Albany, NY 12208 USA Fdn Med, Cambridge, MA USA

Curran, John
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Cronin, Maureen T.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Stephens, Philip J.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Lipson, Doron
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA

Yelensky, Roman
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Med, Cambridge, MA USA Fdn Med, Cambridge, MA USA
[10]
Strategic development of AZD1775, a Wee1 kinase inhibitor, for cancer therapy
[J].
Fu, Siqing
;
Wang, Yudong
;
Keyomarsi, Khandan
;
Meric-Bernstein, Funda
.
EXPERT OPINION ON INVESTIGATIONAL DRUGS,
2018, 27 (09)
:741-751

Fu, Siqing
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Unit 0455,1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Unit 0455,1515 Holcombe Blvd, Houston, TX 77030 USA

Wang, Yudong
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Unit 0455,1515 Holcombe Blvd, Houston, TX 77030 USA
Hebei Med Univ, Dept Med Oncol, Hosp 4, Shijiazhuang, Hebei, Peoples R China Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Unit 0455,1515 Holcombe Blvd, Houston, TX 77030 USA

Keyomarsi, Khandan
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Unit 0455,1515 Holcombe Blvd, Houston, TX 77030 USA

Meric-Bernstein, Funda
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Unit 0455,1515 Holcombe Blvd, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Unit 0455,1515 Holcombe Blvd, Houston, TX 77030 USA